Business product launch

Intco Medical Launches Syntex™ and Synmax Pro Gloves

Analysis based on 7 articles · First reported Apr 03, 2026 · Last updated Apr 03, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The launch of Intco Medical's new synthetic gloves is expected to positively impact the healthcare and industrial protection markets by offering safer, more durable, and compliant alternatives to natural rubber gloves. This innovation addresses supply chain volatility and regulatory pressures, potentially shifting material choices within the disposable glove industry.

Medical Devices Healthcare Industrial Manufacturing

Event Summary

Intco Medical, a global leader in disposable gloves, has expanded its synthetic glove portfolio with the introduction of Syntex™ Synthetic Latex Gloves and Synmax Pro Gloves. These new products are designed to meet the evolving demands of healthcare, food processing, and industrial manufacturing sectors, addressing concerns over natural rubber supply volatility, latex allergies, and stringent sustainability regulations. Syntex™ gloves are sulfur-free and contain no natural rubber latex proteins, complying with U.S. FDA and EU CE standards, and offer high elongation at break and stable resistance. Synmax Pro gloves emphasize enhanced abrasion resistance and durability, with significantly higher abrasion resistance than conventional nitrile gloves. This strategic expansion aims to provide global partners with more adaptive and resilient protective solutions, reinforcing Intco Medical's leadership in the non-latex glove segment.

Key Actions

100 Intco Medical expanded synthetic glove portfolio with Syntex™ and Synmax Pro

80 Intco Medical complied with U.S. FDA and EU CE standards for Syntex™ gloves United States===United States Food and Drug Administration

75 Intco Medical developed sulfur-free and natural rubber latex protein-free formulation for Syntex™

Entities Involved

stock

Intco Medical

Intco Medical has expanded its synthetic glove portfolio with the introduction of Syntex™ Synthetic Latex Gloves and Synmax Pro Gloves, addressing evolving market demands for safety, stability, and compliance. This move strengthens its position as a global leader in disposable non-latex gloves.

Importance 100 Sentiment 40

per

Liu Fangyi

As Chairman of Intco Medical, Liu Fangyi commented on the importance of material innovation, compliance capability, and supply chain resilience in the context of global supply chain adjustments. His statements highlight the strategic thinking behind Intco Medical's new product launches.

Importance 70 Sentiment 20

govactor

United States===United States Food and Drug Administration

The U.S. FDA is mentioned as a regulatory body whose standards the new Syntex™ gloves comply with, indicating the product's adherence to important safety and quality benchmarks for the United States market.

Importance 30 Sentiment 10

alliance

European Union

The European Union's CE standards are met by Syntex™ gloves, and the EU's Regulation on Deforestation-free Products (EUDR) is referenced as a compliance pressure that the new synthetic gloves may help reduce for global buyers.

Importance 30 Sentiment 10

cnt

China

China is mentioned as the country where Intco Medical is based, indicating its origin and operational base.

Importance 10 Sentiment 0

Relationships

Liu Fangyi related ↔ Intco Medical

Intco Medical related ↔ United States===United States Food and Drug Administration

Intco Medical related ↔ European Union

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard